DE19836684A1
(de)
|
1998-08-13 |
2000-02-17 |
Hoechst Schering Agrevo Gmbh |
Herbizide Mittel für tolerante oder resistente Reiskulturen
|
KR100338621B1
(ko)
*
|
2000-01-24 |
2002-05-30 |
전광술 |
제초제 및 그 제조방법
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
ES2372321T3
(es)
|
2001-06-20 |
2012-01-18 |
Genentech, Inc. |
Composiciones y métodos para el diagnóstico y tratamiento de un tumor de pulmón.
|
DE50207026D1
(de)
|
2001-08-23 |
2006-07-06 |
Bayer Cropscience Sa |
Substituierte propargylamine
|
KR101008758B1
(ko)
|
2001-09-18 |
2011-01-14 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
KR100623128B1
(ko)
|
2002-01-02 |
2006-09-14 |
제넨테크, 인크. |
종양의 진단 및 치료 방법 및 이를 위한 조성물
|
KR100429139B1
(ko)
*
|
2002-02-28 |
2004-04-29 |
한국화학연구원 |
싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
|
EP2011886A3
(en)
|
2002-04-16 |
2009-02-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
ZA200507757B
(en)
|
2003-04-04 |
2007-01-31 |
Genentech Inc |
High concentration antibody and protein formulations
|
US6849579B2
(en)
*
|
2003-06-25 |
2005-02-01 |
Pbi Gordon Corporation |
Synergistic quinclorac herbicidal compositions
|
NZ544317A
(en)
|
2003-07-08 |
2009-05-31 |
Genentech Inc |
IL-17 A/F heterologous polypeptides and therapeutic uses thereof
|
ES2472690T3
(es)
|
2003-11-17 |
2014-07-02 |
Genentech, Inc. |
Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico
|
JP4570890B2
(ja)
*
|
2004-03-26 |
2010-10-27 |
協友アグリ株式会社 |
除草剤組成物
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
CN101141981A
(zh)
|
2005-01-21 |
2008-03-12 |
健泰科生物技术公司 |
Her抗体的固定剂量给药
|
KR20070110087A
(ko)
|
2005-02-23 |
2007-11-15 |
알자 코포레이션 |
중추신경계에 활성 약제의 비강 투여
|
EP2399605A1
(en)
|
2005-02-23 |
2011-12-28 |
Genentech, Inc. |
Extending time to disease progression or survival in cancer patients
|
US20090136505A1
(en)
|
2005-02-23 |
2009-05-28 |
Johanna Bentz |
Intranasal Administration of Active Agents to the Central Nervous System
|
WO2006094269A2
(en)
|
2005-03-03 |
2006-09-08 |
Covx Technologies Ireland Limited |
Anti-angiogenic compounds
|
NZ563341A
(en)
|
2005-06-06 |
2009-10-30 |
Genentech Inc |
Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
|
JP2009504183A
(ja)
|
2005-08-15 |
2009-02-05 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、それに関連する組成物および方法
|
WO2007081608A2
(en)
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
US20080311107A1
(en)
|
2006-02-17 |
2008-12-18 |
Genetech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
ES2544957T3
(es)
|
2006-03-21 |
2015-09-07 |
Genentech, Inc. |
Terapia combinada que implica antagonistas alfa5beta1
|
WO2007126455A2
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
US20090288176A1
(en)
|
2006-04-19 |
2009-11-19 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
MX2008015541A
(es)
|
2006-06-06 |
2008-12-18 |
Genentech Inc |
Anticuerpos anti-dll4 y metodos que los usan.
|
US8874380B2
(en)
|
2010-12-09 |
2014-10-28 |
Rutgers, The State University Of New Jersey |
Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
EP2471816A1
(en)
|
2006-08-30 |
2012-07-04 |
Genentech, Inc. |
Multispecific antibodies
|
ATE520712T1
(de)
|
2006-11-10 |
2011-09-15 |
Covx Technologies Ireland Ltd |
Antiangiogene verbindungen
|
ES2379413T3
(es)
|
2007-02-22 |
2012-04-25 |
Genentech, Inc. |
Procedimientos para detectar la enfermedad inflamatoria del intestino
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
CA3006428A1
(en)
|
2007-06-08 |
2008-12-18 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
JP2010533495A
(ja)
|
2007-07-16 |
2010-10-28 |
ジェネンテック, インコーポレイテッド |
ヒト化CD79b抗体およびイムノコンジュゲートならびにそれらの使用
|
PT2176296E
(pt)
|
2007-07-16 |
2012-05-14 |
Genentech Inc |
Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
|
CA2704499C
(en)
|
2007-11-07 |
2020-03-10 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
|
WO2009064805A1
(en)
|
2007-11-12 |
2009-05-22 |
Spaltudaq Corporation |
Compositions and methods for the therapy and diagnosis of influenza
|
MY157403A
(en)
|
2008-01-31 |
2016-06-15 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
WO2009114560A2
(en)
|
2008-03-10 |
2009-09-17 |
Spaltudaq Corporation |
Compositions and methods for the therapy and diagnosis of cytomegalovirus
|
CA2718120A1
(en)
|
2008-03-31 |
2009-10-08 |
Genentech, Inc. |
Compositions and methods for treating and diagnosing asthma
|
CA2723614C
(en)
|
2008-05-16 |
2015-07-14 |
Genentech, Inc. |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
PL2307051T3
(pl)
|
2008-07-08 |
2015-07-31 |
Oncomed Pharm Inc |
Środki wiążące i antagoniści Notch oraz sposoby ich zastosowania
|
EP2318832B1
(en)
|
2008-07-15 |
2013-10-09 |
Academia Sinica |
Glycan arrays on ptfe-like aluminum coated glass slides and related methods
|
CN101352171B
(zh)
*
|
2008-09-19 |
2012-07-04 |
北京燕化永乐农药有限公司 |
吡嘧磺隆与甲羧除草醚农药的除草剂组合物
|
AU2009313902B9
(en)
|
2008-11-13 |
2014-03-27 |
The General Hospital Corporation |
Methods and compositions for regulating iron homeostasis by modulation of BMP-6
|
WO2010062857A1
(en)
|
2008-11-26 |
2010-06-03 |
Allergan, Inc. |
Klk-13 antibody inhibitor for treating dry eye
|
HUE034832T2
(hu)
|
2008-12-09 |
2021-12-28 |
Hoffmann La Roche |
Anti-PD-L1 antitestek és alkalmazásuk T-sejt-funkció fokozására
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
KR20130080871A
(ko)
|
2009-03-20 |
2013-07-15 |
제넨테크, 인크. |
이중특이적 항-her 항체
|
AU2010232692C1
(en)
|
2009-04-01 |
2017-06-01 |
Genentech, Inc. |
Treatment of insulin-resistant disorders
|
JP6132548B2
(ja)
|
2009-04-01 |
2017-05-24 |
ジェネンテック, インコーポレイテッド |
抗FcRH5抗体および免疫接合体および使用方法
|
US20100297127A1
(en)
|
2009-04-08 |
2010-11-25 |
Ghilardi Nico P |
Use of il-27 antagonists to treat lupus
|
US9617600B2
(en)
|
2009-04-18 |
2017-04-11 |
Genentech, Inc. |
Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
|
SG175305A1
(en)
|
2009-04-23 |
2011-11-28 |
Theraclone Sciences Inc |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
US8858948B2
(en)
|
2009-05-20 |
2014-10-14 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2011019679A1
(en)
|
2009-08-11 |
2011-02-17 |
Allergan, Inc. |
Ccr2 inhibitors for treating conditions of the eye
|
ES2564207T3
(es)
|
2009-10-22 |
2016-03-18 |
F. Hoffmann-La Roche Ag |
Métodos y composiciones para modular la activación con hepsina de la proteína estimuladora de macrófagos
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
JP6139885B2
(ja)
|
2009-10-26 |
2017-05-31 |
ジェネンテック, インコーポレイテッド |
治療的抗IgE抗体に特異的な抗体を検出するためのアッセイ及びアナフィラキシーにおけるそれらの使用
|
EP3002297B1
(en)
|
2009-11-30 |
2020-04-08 |
F. Hoffmann-La Roche AG |
Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211)
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011082187A1
(en)
|
2009-12-30 |
2011-07-07 |
Genentech, Inc. |
Methods for modulating a pdgf-aa mediated biological response
|
KR20130004579A
(ko)
|
2010-02-23 |
2013-01-11 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
JP2013525484A
(ja)
|
2010-05-03 |
2013-06-20 |
ジェネンテック, インコーポレイテッド |
タンパク質含有製剤の粘度を低減させるために有用な組成物及び方法
|
AU2011250970B2
(en)
|
2010-05-10 |
2016-12-15 |
Sinica, Academia |
Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
|
CN102265853A
(zh)
*
|
2010-06-04 |
2011-12-07 |
南京华洲药业有限公司 |
一种含灭草松和二氯喹啉酸的除草组合物及其应用
|
US20110311527A1
(en)
|
2010-06-16 |
2011-12-22 |
Allergan, Inc. |
IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
US8900590B2
(en)
|
2010-08-12 |
2014-12-02 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
EP2603526A1
(en)
|
2010-08-13 |
2013-06-19 |
Medimmune Limited |
Monomeric polypeptides comprising variant fc regions and methods of use
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
CA3109036C
(en)
|
2010-08-31 |
2023-08-01 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
KR20140012098A
(ko)
|
2011-02-14 |
2014-01-29 |
테라클론 사이언시스, 아이엔씨. |
인플루엔자의 치료 및 진단을 위한 조성물 및 방법
|
SG193402A1
(en)
|
2011-03-15 |
2013-10-30 |
Theraclone Sciences Inc |
Compositions and methods for the therapy and diagnosis of influenza
|
CA2831732C
(en)
|
2011-03-31 |
2019-12-31 |
Genentech, Inc. |
Use of a monoclonal anti-beta7 antibody for treating gastrointestinal inflammatory disorders
|
CN103648530B
(zh)
|
2011-05-08 |
2017-02-08 |
乐高化学生物科学股份有限公司 |
蛋白质‑活性剂缀合物及其制备方法
|
BR112013029550A2
(pt)
|
2011-05-17 |
2022-04-19 |
California Inst Of Techn |
Anticorpos neutralizantes de vírus de imunodeficiência humana e métodos de uso dos mesmos
|
JP6305919B2
(ja)
|
2011-06-06 |
2018-04-04 |
プロセナ バイオサイエンシーズ リミテッド |
Mcamアンタゴニスト及び治療の方法
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
US9120858B2
(en)
|
2011-07-22 |
2015-09-01 |
The Research Foundation Of State University Of New York |
Antibodies to the B12-transcobalamin receptor
|
WO2013015821A1
(en)
|
2011-07-22 |
2013-01-31 |
The Research Foundation Of State University Of New York |
Antibodies to the b12-transcobalamin receptor
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
US9890207B2
(en)
|
2011-07-25 |
2018-02-13 |
California Institute Of Technology |
Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
|
WO2013033069A1
(en)
|
2011-08-30 |
2013-03-07 |
Theraclone Sciences, Inc. |
Human rhinovirus (hrv) antibodies
|
EP3663314A1
(en)
|
2012-01-09 |
2020-06-10 |
The Scripps Research Institute |
Humanized antibodies with ultralong cdr3s
|
JP6684490B2
(ja)
|
2012-01-09 |
2020-04-22 |
ザ・スクリップス・リサーチ・インスティテュート |
超長相補性決定領域及びその使用
|
TW201334789A
(zh)
|
2012-01-31 |
2013-09-01 |
Genentech Inc |
抗ige抗體及其使用方法
|
AU2013240344A1
(en)
|
2012-03-27 |
2014-09-18 |
Genentech, Inc. |
Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
|
BR112014024017A8
(pt)
|
2012-03-27 |
2017-07-25 |
Genentech Inc |
Métodos de tratamento de um tipo de câncer, de tratamento do carcinoma, para selecionar uma terapia e para quantificação e inibidor de her3
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013192589A1
(en)
|
2012-06-21 |
2013-12-27 |
California Institute Of Technology |
Antibodies targeting hiv escape mutants
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
AU2013305827A1
(en)
|
2012-08-21 |
2015-03-05 |
Academia Sinica |
Benzocyclooctyne compounds and uses thereof
|
TWI660972B
(zh)
|
2012-09-10 |
2019-06-01 |
愛爾蘭商尼歐托普生物科學公司 |
抗mcam抗體及相關使用方法
|
RU2015112024A
(ru)
|
2012-10-05 |
2016-11-27 |
Дженентек, Инк. |
Способы диагностики и лечения воспалительного заболевания кишечника
|
LT2908912T
(lt)
|
2012-10-18 |
2020-09-25 |
The Rockefeller University |
Plačiai neutralizuojantys anti-živ antikūnai
|
AU2013334493B2
(en)
|
2012-10-26 |
2018-11-29 |
The University Of Queensland |
Use of endocytosis inhibitors and antibodies for cancer therapy
|
SG11201507974RA
(en)
|
2013-03-27 |
2015-10-29 |
Genentech Inc |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
EP2983710B1
(en)
|
2013-04-09 |
2019-07-31 |
Annexon, Inc. |
Methods of treatment for neuromyelitis optica
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
WO2015006507A1
(en)
|
2013-07-09 |
2015-01-15 |
Annexon, Inc. |
Methods of treatment for alzheimer's disease and huntington's disease
|
EP3022221B1
(en)
|
2013-07-18 |
2021-09-15 |
Taurus Biosciences, LLC |
Humanized antibodies with ultralong complementarity determining regions
|
US20160168231A1
(en)
|
2013-07-18 |
2016-06-16 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
RU2732032C2
(ru)
|
2013-12-20 |
2020-09-10 |
Дженентек, Инк. |
Антитела с двойной специфичностью
|
CA2936488C
(en)
|
2014-01-14 |
2022-05-03 |
The Medical College Of Wisconsin, Inc. |
Targeting clptm1l for treatment and prevention of cancer
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
KR20160104727A
(ko)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
암의 치료 및 검출을 위한 조성물 및 방법
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
CA2939246A1
(en)
|
2014-03-27 |
2015-10-01 |
Genentech, Inc. |
Methods for diagnosing and treating inflammatory bowel disease
|
CN104012549B
(zh)
*
|
2014-05-07 |
2016-08-17 |
广东中迅农科股份有限公司 |
一种含有双唑草腈和双草醚的除草组合物
|
CN104012547A
(zh)
*
|
2014-05-07 |
2014-09-03 |
广东中迅农科股份有限公司 |
一种含有双唑草腈和氰氟草酯的除草组合物
|
EP3888690A3
(en)
|
2014-05-16 |
2021-10-20 |
MedImmune, LLC |
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
|
KR20170005142A
(ko)
|
2014-05-27 |
2017-01-11 |
아카데미아 시니카 |
증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
|
EP3149037A4
(en)
|
2014-05-27 |
2018-01-10 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
EP3149036A4
(en)
|
2014-05-27 |
2017-12-27 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
JP7063538B2
(ja)
|
2014-05-28 |
2022-05-09 |
アカデミア シニカ |
抗TNFα糖操作抗体群およびその使用
|
ES2905777T3
(es)
|
2014-05-30 |
2022-04-12 |
Shanghai Henlius Biotech Inc |
Anticuerpos anti-receptor del factor de crecimiento epidérmico (EGFR)
|
CA3090240A1
(en)
|
2014-08-08 |
2016-02-11 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
TWI745275B
(zh)
|
2014-09-08 |
2021-11-11 |
中央研究院 |
使用醣脂激活人類iNKT細胞
|
CN104255750A
(zh)
*
|
2014-09-10 |
2015-01-07 |
广东中迅农科股份有限公司 |
含有双唑草腈和丙草胺的除草组合物
|
WO2016073157A1
(en)
|
2014-11-06 |
2016-05-12 |
Genentech, Inc. |
Anti-ang2 antibodies and methods of use thereof
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EA033465B1
(ru)
|
2015-01-22 |
2019-10-31 |
Basf Agro Bv |
Трехкомпонентная гербицидная комбинация, включающая сафлуфенацил
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
WO2016123329A2
(en)
|
2015-01-28 |
2016-08-04 |
Genentech, Inc. |
Gene expression markers and treatment of multiple sclerosis
|
KR20170120601A
(ko)
|
2015-02-26 |
2017-10-31 |
제넨테크, 인크. |
인테그린 베타7 길항제 및 크론병을 치료하는 방법
|
KR20170132793A
(ko)
|
2015-04-03 |
2017-12-04 |
유레카 쎄라퓨틱스, 인코포레이티드 |
Afp 펩티드/mhc 복합체를 표적화하는 구축물 및 그의 용도
|
EP3280441B1
(en)
|
2015-04-07 |
2021-09-29 |
Alector LLC |
Anti-sortilin antibodies and methods of use thereof
|
CN104757013A
(zh)
*
|
2015-04-18 |
2015-07-08 |
广东中迅农科股份有限公司 |
含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
|
WO2016191811A1
(en)
|
2015-06-03 |
2016-12-08 |
The University Of Queensland |
Mobilizing agents and uses therefor
|
CA2988982A1
(en)
|
2015-06-12 |
2016-12-15 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
US11174313B2
(en)
|
2015-06-12 |
2021-11-16 |
Alector Llc |
Anti-CD33 antibodies and methods of use thereof
|
EP3319427B1
(en)
|
2015-07-10 |
2019-04-17 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and dimethenamid
|
US11219215B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
|
CN107846891B
(zh)
|
2015-07-10 |
2024-02-20 |
巴斯夫农业公司 |
包含环庚草醚和特异性色素合成抑制剂的除草组合物
|
WO2017009061A1
(en)
|
2015-07-10 |
2017-01-19 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and saflufenacil
|
PL3319434T3
(pl)
|
2015-07-10 |
2019-11-29 |
Basf Agro Bv |
Kompozycja chwastobójcza zawierająca cynmetylinę i petoksamid
|
US11219212B2
(en)
|
2015-07-10 |
2022-01-11 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and imazamox
|
WO2017009144A1
(en)
*
|
2015-07-10 |
2017-01-19 |
BASF Agro B.V. |
Herbicidal composition comprising cinmethylin and specific quinolinecarboxylic acids
|
JP6875369B2
(ja)
|
2015-07-10 |
2021-05-26 |
ビーエーエスエフ アグロ ベー.ブイ. |
シンメチリン及びピロキサスルホンを含む除草剤組成物
|
JP6875368B2
(ja)
|
2015-07-10 |
2021-05-26 |
ビーエーエスエフ アグロ ベー.ブイ. |
シンメチリン及びアセトクロール又はプレチラクロールを含む除草剤組成物
|
CN105076162B
(zh)
*
|
2015-08-05 |
2018-03-09 |
安徽华星化工有限公司 |
一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
|
CN115960235A
(zh)
|
2015-08-28 |
2023-04-14 |
艾利妥 |
抗siglec-7抗体及其使用方法
|
CN117069841A
(zh)
|
2015-10-06 |
2023-11-17 |
艾利妥 |
抗trem2抗体及其使用方法
|
CN115927191A
(zh)
|
2015-10-23 |
2023-04-07 |
优瑞科生物技术公司 |
抗体/t细胞受体嵌合构建体及其用途
|
SG11201803567XA
(en)
|
2015-10-29 |
2018-05-30 |
Alector Llc |
Anti-siglec-9 antibodies and methods of use thereof
|
AU2016359230B2
(en)
|
2015-11-25 |
2020-04-23 |
Legochem Biosciences, Inc. |
Conjugates comprising self-immolative groups and methods related thereto
|
KR20180098625A
(ko)
|
2015-12-30 |
2018-09-04 |
제넨테크, 인크. |
분해가 감소된 폴리소르베이트를 갖는 제형
|
EP3423493A2
(en)
|
2016-03-04 |
2019-01-09 |
Alector LLC |
Anti-trem1 antibodies and methods of use thereof
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
CN105901005A
(zh)
*
|
2016-05-16 |
2016-08-31 |
河北博嘉农业有限公司 |
一种含有双唑草腈的除草组合物
|
CN105918339A
(zh)
*
|
2016-05-19 |
2016-09-07 |
河北博嘉农业有限公司 |
一种含有双唑草腈和磺酰脲类除草剂的除草组合物
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
WO2018052818A1
(en)
|
2016-09-16 |
2018-03-22 |
Henlix, Inc. |
Anti-pd-1 antibodies
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
CN108064868A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064865A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064860A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN106561695A
(zh)
*
|
2016-11-15 |
2017-04-19 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064871A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
CN108064866A
(zh)
*
|
2016-11-15 |
2018-05-25 |
江苏龙灯化学有限公司 |
一种除草组合物
|
KR102085798B1
(ko)
|
2016-12-28 |
2020-03-06 |
주식회사 인투셀 |
베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
|
TW201831517A
(zh)
|
2017-01-12 |
2018-09-01 |
美商優瑞科生物技術公司 |
靶向組織蛋白h3肽/mhc複合體之構築體及其用途
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
CN107047578A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
|
CN107047594A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
|
CN106857578A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与乙草胺的除草组合物及其应用
|
CN107047592A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
|
CN106857576A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
|
CN106857600A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与异丙隆的除草组合物及其应用
|
CN106857577A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与氟硫草定的除草组合物及其应用
|
CN106857575A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与丁草胺的除草组合物及其应用
|
CN106857580A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
|
CN106857579A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
|
CN106889083B
(zh)
*
|
2017-02-27 |
2019-02-12 |
南京华洲药业有限公司 |
一种含双唑草腈与异恶草酮的除草组合物及其应用
|
CN107047582A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与禾草畏的除草组合物及其应用
|
CN106889094A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
|
CN106857621A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与禾草敌的除草组合物及其应用
|
CN106889082A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与噁草酮的除草组合物及其应用
|
CN107047593A
(zh)
*
|
2017-02-27 |
2017-08-18 |
南京华洲药业有限公司 |
一种含双唑草腈与乙氧磺隆的除草组合物及其应用
|
CN106889084A
(zh)
*
|
2017-02-27 |
2017-06-27 |
南京华洲药业有限公司 |
一种含双唑草腈与灭草松的除草组合物及其应用
|
CN106857609A
(zh)
*
|
2017-02-27 |
2017-06-20 |
南京华洲药业有限公司 |
一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
|
RU2665790C1
(ru)
|
2017-04-17 |
2018-09-04 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело к pd-l1
|
EP3615569A1
(en)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
KR102663596B1
(ko)
|
2017-04-26 |
2024-05-10 |
유레카 쎄라퓨틱스, 인코포레이티드 |
글리피칸 3을 특이적으로 인식하는 구축물 및 그의 용도
|
IL310182A
(en)
|
2017-04-26 |
2024-03-01 |
Eureka Therapeutics Inc ׂ A Delaware Corp |
Structures of chimeric antibody/T-cell receptor and uses thereof
|
EP3625258A1
(en)
|
2017-05-16 |
2020-03-25 |
Alector LLC |
Anti-siglec-5 antibodies and methods of use thereof
|
CN107094781A
(zh)
*
|
2017-05-22 |
2017-08-29 |
孙金金 |
一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
|
CN106954634A
(zh)
*
|
2017-05-22 |
2017-07-18 |
娄天成 |
一种含双唑草腈和莎稗磷的农药组合物及其应用
|
CN107114382A
(zh)
*
|
2017-05-22 |
2017-09-01 |
娄天成 |
一种含双唑草腈和敌稗的农药组合物及其应用
|
EP3630830A1
(en)
|
2017-05-23 |
2020-04-08 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel cd73 antibody, preparation and uses thereof
|
CN107006498A
(zh)
*
|
2017-05-24 |
2017-08-04 |
江苏省农用激素工程技术研究中心有限公司 |
用于防除稻田杂草的除草组合物
|
RU2653545C1
(ru)
*
|
2017-07-17 |
2018-05-11 |
АО "Щелково Агрохим" |
Гербицидная композиция на основе бентазона для защиты зернобобовых культур
|
EP3655430A1
(en)
|
2017-07-19 |
2020-05-27 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
|
RS64419B1
(sr)
|
2017-08-03 |
2023-09-29 |
Alector Llc |
Anti-trem2 antitela i postupci za njihovu upotrebu
|
EP3589658A1
(en)
|
2017-08-03 |
2020-01-08 |
Alector LLC |
Anti-cd33 antibodies and methods of use thereof
|
EA039662B1
(ru)
|
2017-10-03 |
2022-02-24 |
Закрытое Акционерное Общество "Биокад" |
Антитела, специфичные к cd47 и pd-l1
|
RU2698048C2
(ru)
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
CA3085472A1
(en)
|
2017-12-19 |
2019-06-27 |
The Rockefeller University |
Human igg fc domain variants with improved effector function
|
KR20200104333A
(ko)
|
2017-12-28 |
2020-09-03 |
난징 레전드 바이오테크 씨오., 엘티디. |
Tigit에 대한 단일-도메인 항체 및 이의 변이체
|
CA3084518A1
(en)
|
2018-01-15 |
2019-07-18 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against pd-1
|
CN111954541A
(zh)
|
2018-01-25 |
2020-11-17 |
Acm生物实验室私人有限公司 |
包含可溶性包封抗原的聚合物囊泡以及其制备方法和用途
|
CN108371183A
(zh)
*
|
2018-02-02 |
2018-08-07 |
河北中天邦正生物科技股份公司 |
一种农药组合物及其应用
|
CN108308187A
(zh)
*
|
2018-02-11 |
2018-07-24 |
河北中天邦正生物科技股份公司 |
一种农药组合物及其应用
|
US11958903B2
(en)
|
2018-03-30 |
2024-04-16 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against LAG-3 and uses thereof
|
US20210171610A1
(en)
|
2018-05-02 |
2021-06-10 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
US11993661B2
(en)
|
2018-06-18 |
2024-05-28 |
Eureka Therapeutics, Inc. |
Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof
|
KR20230065382A
(ko)
|
2018-07-13 |
2023-05-11 |
알렉터 엘엘씨 |
항-소틸린 항체 및 이들의 사용 방법
|
CN112334479A
(zh)
|
2018-07-13 |
2021-02-05 |
南京传奇生物科技有限公司 |
用于治疗感染性疾病的共受体系统
|
CA3106535A1
(en)
|
2018-07-27 |
2020-01-30 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
US20220105176A1
(en)
|
2018-09-12 |
2022-04-07 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
|
RU2724469C2
(ru)
|
2018-10-31 |
2020-06-23 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с cd20
|
KR20210101235A
(ko)
|
2018-11-16 |
2021-08-18 |
메모리얼 슬로안 케터링 캔서 센터 |
뮤신-16에 대한 항체 및 이의 사용 방법
|
RU2734432C1
(ru)
|
2019-04-23 |
2020-10-16 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с GITR
|
JP2022530482A
(ja)
|
2019-05-02 |
2022-06-29 |
レゴケム バイオサイエンシズ, インク. |
トリス構造を有するリンカーを含むリガンド―薬物複合体
|
BR112021026492A2
(pt)
|
2019-06-28 |
2022-02-08 |
Genentech Inc |
Formulações líquidas, formulação liofilizada, artigos de fabricação e método para preparar uma formulação líquida
|
CN110178842A
(zh)
*
|
2019-07-05 |
2019-08-30 |
南京农业大学 |
一种丙草胺与双唑草腈治理抗性稗组合物及其应用
|
CN114423787A
(zh)
|
2019-07-19 |
2022-04-29 |
昂科里斯庞斯公司 |
免疫调节性抗体及其使用方法
|
CN112300279A
(zh)
|
2019-07-26 |
2021-02-02 |
上海复宏汉霖生物技术股份有限公司 |
针对抗cd73抗体和变体的方法和组合物
|
WO2021238886A1
(en)
|
2020-05-27 |
2021-12-02 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
Antibodies specifically recognizing nerve growth factor and uses thereof
|
MX2023008485A
(es)
|
2021-01-20 |
2023-07-28 |
Oncoresponse Inc |
Anticuerpos inmunomoduladores y usos de estos.
|
WO2022218957A1
(en)
|
2021-04-12 |
2022-10-20 |
Acm Biolabs Pte Ltd |
Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
|
EP4367139A1
(en)
|
2021-07-08 |
2024-05-15 |
Staidson Biopharma Inc. |
Antibodies specifically recognizing tnfr2 and uses thereof
|
KR20240058075A
(ko)
|
2021-07-14 |
2024-05-03 |
스테이드슨 (베이징) 바이오팔마슈티칼스 캄퍼니 리미티드 |
Cd40을 특이적으로 식별하는 항체 및 이의 응용
|
WO2024020407A1
(en)
|
2022-07-19 |
2024-01-25 |
Staidson Biopharma Inc. |
Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereof
|